Skip to main content

Advertisement

Log in

Mechanistic prospective and pharmacological attributes of quercetin in attenuation of different types of arthritis

  • Review Article
  • Published:
3 Biotech Aims and scope Submit manuscript

Abstract

Arthritis is a frequent autoimmune disease with undefined etiology and pathogenesis. Scientific community constantly fascinating quercetin (QUR), as it is the best-known flavonoid among others for curative and preventive properties against a wide range of diseases. Due to its multifaceted activities, the implementation of QUR against various types of arthritis namely, rheumatoid arthritis (RA), osteoarthritis (OA), gouty arthritis (GA) and psoriotic arthritis (PsA) has greatly increased in recent years. Many research evidenced that QUR regulates a wide range of pathways for instance NF-κB, MAK, Wnt/β-catenine, Notch, etc., that are majorly associated with the inflammatory mechanisms. Besides, the bioavailability of QUR is a major constrain to its therapeutic potential, and drug delivery techniques have experienced significant development to overcome the problem of its limited application. Hence, this review compiled the cutting-edge experiments on versatile effects of QUR on inflammatory diseases like RA, OA, GA and PsA, sources and bioavailability, therapeutic challenges, pharmacokinetics, clinical studies as well as toxicological impacts. The use of QUR in a health context would offer a tearing and potential therapeutic method, supporting the advancement of public health, particularly, of arthritic patients worldwide.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig.3
Fig. 4
Fig. 5

Similar content being viewed by others

Availability of data and materials

Not Applicable.

Code availability

Not Applicable.

Abbreviations

AIM2:

Absent in melanoma 2

ADME:

Absorption, distribution, metabolism, and excretion

ADA:

Adenosine deaminase

AIA:

Adjuvant-induced arthritic

ALP:

Alkaline phosphatase

ASC:

Apoptosis-associated speck-like protein containing CARD

CaC2O4 :

Calcium oxalate

CCL:

C–C motif chemokine ligand

JNK:

C-Jun N-terminal kinase

CD14:

Cluster of differentiation14

CoPP:

Cobalt protoporphyrin IX

CIA:

Collagen-induced arthritic

C3:

Complement protein 3

CFA:

Complete Freund adjuvant

COX:

Cyclooxygenase

E-ADA:

Ectoadenosine deaminase

ENM:

Electrospun nanofiber membrane

ECM:

Extracellular matrix

FLS:

Fibroblst like synovium

GATA6:

GATA transcription factor 6

GO:

Gene ontology

GA:

Gout arthritis

HO:

Heme oxygenase

H:

Hydrogen

HIF-1:

Hypoxia-inducible factor-1

iNOS:

Inducible nitric oxide synthase

IL:

Interleukin

KOA:

Knee-OA

KEGG:

Kyoto Encyclopedia of Genes and Genomes

LII:

Limb idleness index

LOX:

Lipooxigenase

LPS:

Lipopolysaccharides

M1:

Secretes pro-inflammatory cytokines

M2:

Secretes anti-inflammatory cytokines

MMPs:

Matrix metalloproteinases

MTX:

Methotrexate

mPEG-PA:

Methyl-poly(ethylene glycol)-l-poly(alanine)

MIA:

Monoiodoacetate

MSU:

Monosodium urate

MPO:

Myeloperoxidase

NK:

Natural killer cells

NO:

Nitric oxide

NLRP3:

NLR protein3

NLR:

Nod-like receptor

Nrf2:

Nuclear factor erythroid2-related factor

RANKL:

Nuclear factor kappa-Β ligand

NF:

Nuclear factor

OAT1:

Organic anion transport1

OA:

Osteoarthritis

P2X7R:

P2X, NLRP3, ligand-gated ion channel7

PG:

Prostaglandin

PsA:

Psoriatic arthritis

QUR:

Quercetin

ROS:

Reactive oxygen species

CRP:

Reactive protein C

RA:

Rheumatoid arthritis

RF:

Rheumatoid factor

SMP:

Sanmiao pill

SASP:

Senescence-associated secretary phenotype

SMP:

Simiao Powder

TMJ:

Temporomandibular joint

TBHP:

Tert-butyl hydroperoxide

TXNIP:

Thioredoxin interacting protein

TIMP1:

Tissue inhibitor matrix metalloproteinase1

TLR4:

Toll-like receptor4

TCM:

Traditional Chinese medicines

TNF-α:

Tumor necrosis factor

VEGF:

Vascular endothelial growth factor

XFG:

Xiaofeng Granule

ZSD:

ZishengShenqi Decoction

ZIA:

Zymosan-induced arthritic

References

Download references

Acknowledgements

The authors would like to thank the University Grants Commission, New Delhi, and Council of Scientific and Industrial Research, New Delhi, for awarding fellowship to Anita Bhoi under Research Fellowship [F.No. 16-6(DEC. 2018)/2019(NET/CSIR), dated July 24, 2019]. The author would also like to acknowledge DHR-ICMR project no: V.25011/286-HRD/2016-HR for financial support.

Funding

The authors would like to thank the University Grants Commission, New Delhi, and the Council of Scientific and Industrial Research, New Delhi, for awarding a fellowship to Anita Bhoi under Research Fellowship [F.No. 16–6(DEC. 2018)/2019(NET/CSIR), dated July 24, 2019]. The author would also like to acknowledge DHR-ICMR project no: V.25011/286-HRD/2016-HR for financial support.

Author information

Authors and Affiliations

Authors

Contributions

MRS and SK:—conceptualized the topic; AB:—Writing- Original draft preparation; SDD:—Gathering information; DS:—Reviewing and Editing.

Corresponding author

Correspondence to Manju Rawat Singh.

Ethics declarations

Conflict of interest

Authors have no conflict of interest.

Ethical approval

Not Applicable.

Consent to participate

Not Applicable.

Consent for publication

Not Applicable.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bhoi, A., Dwivedi, S.D., Singh, D. et al. Mechanistic prospective and pharmacological attributes of quercetin in attenuation of different types of arthritis. 3 Biotech 13, 362 (2023). https://doi.org/10.1007/s13205-023-03787-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s13205-023-03787-6

Keywords

Navigation